vs

Side-by-side financial comparison of Logistic Properties of the Americas (LPA) and RECURSION PHARMACEUTICALS, INC. (RXRX). Click either name above to swap in a different company.

Logistic Properties of the Americas is the larger business by last-quarter revenue ($50.1M vs $35.5M, roughly 1.4× RECURSION PHARMACEUTICALS, INC.). Logistic Properties of the Americas runs the higher net margin — 32.1% vs -304.2%, a 336.4% gap on every dollar of revenue. Logistic Properties of the Americas produced more free cash flow last quarter ($21.4M vs $-47.3M).

Logistic Properties of the Americas is a specialized industrial real estate firm that acquires, develops and manages logistics properties across North, Central and South America. Its portfolio includes distribution centers, warehouses and last-mile delivery facilities, serving e-commerce, retail, manufacturing and third-party logistics clients.

Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines artificial intelligence and large-scale high-throughput biological experimentation to discover and develop innovative therapies for rare diseases, oncology, inflammatory disorders, and other areas of unmet medical need. It primarily operates in North America and partners with global biopharmaceutical firms to advance its robust therapeutic pipeline.

LPA vs RXRX — Head-to-Head

Bigger by revenue
LPA
LPA
1.4× larger
LPA
$50.1M
$35.5M
RXRX
Higher net margin
LPA
LPA
336.4% more per $
LPA
32.1%
-304.2%
RXRX
More free cash flow
LPA
LPA
$68.7M more FCF
LPA
$21.4M
$-47.3M
RXRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LPA
LPA
RXRX
RXRX
Revenue
$50.1M
$35.5M
Net Profit
$16.1M
$-108.1M
Gross Margin
59.8%
Operating Margin
81.7%
-304.8%
Net Margin
32.1%
-304.2%
Revenue YoY
681.7%
Net Profit YoY
39.6%
EPS (diluted)
$0.33
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LPA
LPA
RXRX
RXRX
Q4 25
$50.1M
$35.5M
Q3 25
$32.7M
$5.2M
Q2 25
$21.5M
$19.2M
Q1 25
$10.5M
$14.7M
Q4 24
$4.5M
Q3 24
$19.2M
$26.1M
Q2 24
$14.4M
Q1 24
$9.2M
$13.8M
Net Profit
LPA
LPA
RXRX
RXRX
Q4 25
$16.1M
$-108.1M
Q3 25
$-162.3M
Q2 25
$-171.9M
Q1 25
$-202.5M
Q4 24
$-178.9M
Q3 24
$-95.8M
Q2 24
$-97.5M
Q1 24
$-91.4M
Gross Margin
LPA
LPA
RXRX
RXRX
Q4 25
59.8%
Q3 25
-183.8%
Q2 25
-4.9%
Q1 25
-48.0%
Q4 24
-181.4%
Q3 24
53.7%
Q2 24
36.2%
Q1 24
19.1%
Operating Margin
LPA
LPA
RXRX
RXRX
Q4 25
81.7%
-304.8%
Q3 25
-3327.6%
Q2 25
-916.8%
Q1 25
-1297.9%
Q4 24
-4042.4%
Q3 24
-377.1%
Q2 24
-697.4%
Q1 24
-698.4%
Net Margin
LPA
LPA
RXRX
RXRX
Q4 25
32.1%
-304.2%
Q3 25
-3135.3%
Q2 25
-894.2%
Q1 25
-1373.3%
Q4 24
-3935.5%
Q3 24
-367.5%
Q2 24
-676.6%
Q1 24
-662.4%
EPS (diluted)
LPA
LPA
RXRX
RXRX
Q4 25
$0.33
$-0.17
Q3 25
$0.09
$-0.36
Q2 25
$-0.06
$-0.41
Q1 25
$-0.50
Q4 24
$-0.56
Q3 24
$-1.26
$-0.34
Q2 24
$-0.40
Q1 24
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LPA
LPA
RXRX
RXRX
Cash + ST InvestmentsLiquidity on hand
$27.3M
$743.3M
Total DebtLower is stronger
$296.8M
$9.6M
Stockholders' EquityBook value
$324.6M
$1.1B
Total Assets
$700.8M
$1.5B
Debt / EquityLower = less leverage
0.91×
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LPA
LPA
RXRX
RXRX
Q4 25
$27.3M
$743.3M
Q3 25
$659.8M
Q2 25
$525.1M
Q1 25
$500.5M
Q4 24
$594.4M
Q3 24
$427.6M
Q2 24
$474.3M
Q1 24
$1.1M
$296.3M
Total Debt
LPA
LPA
RXRX
RXRX
Q4 25
$296.8M
$9.6M
Q3 25
$11.9M
Q2 25
$14.2M
Q1 25
$16.4M
Q4 24
$19.0M
Q3 24
$20.5M
Q2 24
$22.9M
Q1 24
Stockholders' Equity
LPA
LPA
RXRX
RXRX
Q4 25
$324.6M
$1.1B
Q3 25
$1.0B
Q2 25
$919.1M
Q1 25
$933.9M
Q4 24
$1.0B
Q3 24
$524.6M
Q2 24
$584.4M
Q1 24
$401.2M
Total Assets
LPA
LPA
RXRX
RXRX
Q4 25
$700.8M
$1.5B
Q3 25
$1.4B
Q2 25
$1.3B
Q1 25
$1.3B
Q4 24
$1.4B
Q3 24
$726.5M
Q2 24
$775.9M
Q1 24
$557.8M
Debt / Equity
LPA
LPA
RXRX
RXRX
Q4 25
0.91×
0.01×
Q3 25
0.01×
Q2 25
0.02×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.04×
Q2 24
0.04×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LPA
LPA
RXRX
RXRX
Operating Cash FlowLast quarter
$21.6M
$-46.1M
Free Cash FlowOCF − Capex
$21.4M
$-47.3M
FCF MarginFCF / Revenue
42.7%
-133.1%
Capex IntensityCapex / Revenue
0.3%
3.5%
Cash ConversionOCF / Net Profit
1.34×
TTM Free Cash FlowTrailing 4 quarters
$12.0M
$-378.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LPA
LPA
RXRX
RXRX
Q4 25
$21.6M
$-46.1M
Q3 25
$14.4M
$-117.4M
Q2 25
$7.2M
$-76.4M
Q1 25
$4.4M
$-132.0M
Q4 24
$-115.4M
Q3 24
$8.3M
$-59.2M
Q2 24
$-82.2M
Q1 24
$4.8M
$-102.3M
Free Cash Flow
LPA
LPA
RXRX
RXRX
Q4 25
$21.4M
$-47.3M
Q3 25
$-7.3M
$-117.6M
Q2 25
$-3.1M
$-79.6M
Q1 25
$966.4K
$-133.8M
Q4 24
$-116.7M
Q3 24
$-2.4M
$-63.8M
Q2 24
$-83.4M
Q1 24
$218.9K
$-109.0M
FCF Margin
LPA
LPA
RXRX
RXRX
Q4 25
42.7%
-133.1%
Q3 25
-22.2%
-2272.5%
Q2 25
-14.4%
-413.9%
Q1 25
9.2%
-907.4%
Q4 24
-2567.7%
Q3 24
-12.3%
-244.6%
Q2 24
-578.5%
Q1 24
2.4%
-789.9%
Capex Intensity
LPA
LPA
RXRX
RXRX
Q4 25
0.3%
3.5%
Q3 25
66.1%
4.7%
Q2 25
47.9%
16.4%
Q1 25
32.5%
12.4%
Q4 24
28.6%
Q3 24
55.5%
17.5%
Q2 24
8.2%
Q1 24
50.0%
48.2%
Cash Conversion
LPA
LPA
RXRX
RXRX
Q4 25
1.34×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons